Safety Concerns With HPV Vaccines Continue to Linger: Are Current Vaccine Pharmacovigilance Practices Sufficient?

Drug Safety - United Kingdom
doi 10.1007/s40264-017-0593-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Global Vaccine Safety Initiative: Enhancing Vaccine Pharmacovigilance Capacity at Country Level

Bulletin of the World Health Organization
EnvironmentalPublic HealthOccupational Health
2014English

Vaccine Update: Recent Progress With Novel Vaccines, and New Approaches to Safety Monitoring and Vaccine Shortage

Journal of Clinical Pharmacology
Pharmacology
2018English

Current State in the Development of Candidate Therapeutic HPV Vaccines

Expert Review of Vaccines
Molecular MedicineDrug DiscoveryImmunologyPharmacology
2016English

Safety Profile of HPV Vaccines: An Analysis of the USA Vaccine Adverse Event Reporting System (VAERS) From 2007-2017

British Journal of Clinical Pharmacology
Pharmacology
2019English

Prophylactic HPV Vaccines

Journal of Clinical Pathology
MedicineForensic MedicinePathology
2006English

Characterizing Safety-Net Providers’ HPV Vaccine Recommendations to Undecided Parents: A Pilot Study

Patient Education and Counseling
Medicine
2016English

Hospital DoctorsÂ’ Views and Concerns About Pharmacovigilance

Journal of Pharmacovigilance
2015English

HPV Vaccines? Still Needed

Current Oncology
Oncology
2016English

Therapeutic HPV DNA Vaccines

Expert Review of Vaccines
Molecular MedicineDrug DiscoveryImmunologyPharmacology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy